Novo Nordisk A/S
Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list
The CNBC Investing Club held its April Monthly Meeting on Thursday, with Jim Cramer and Jeff Marks, director of portfolio analysis, hashing it out on each stock in the portfolio. The confab came a day after the S & P 500 closed at its first record high since late January, punctuating its dramatic comeback from […]
Read More
Inside India newsletter: Small towns are powering e-commerce’s fastest-growing market, dominated by Amazon, Walmart unit
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India“ — your one-stop destination for stories and developments from the world’s fastest growing large economy. Amazon and Walmart’s Flipkart dominate India’s e‑commerce market. This week, I unpack why the U.S. giants are keen to expand in the […]
Read More
Nearly 60% of U.S. farmers say their finances are getting worse as fertilizer, fuel costs rise: Survey
Fertilizer is spread across a field in China Grove, North Carolina, on April 10, 2026. Grant Baldwin | AFP | Getty Images On a farm in Goldsboro, North Carolina, where her husband’s family has worked the land for generations, Lorenda Overman is facing familiar hurdles — but also new pressures she couldn’t have predicted only […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, JPMorgan Chase, United Airlines & more
Check out the companies making the biggest moves premarket: Novo Nordisk — U.S.-listed shares popped 3% after the company announced a partnership with OpenAI . “Integrating AI in our everyday work gives us the ability to analyse datasets at a scale that was previously impossible, identify patterns we could not see, and test hypotheses faster […]
Read More
Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark, March 26, 2026. Tom Little | Reuters Novo Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday. The partnership will enable Novo to better […]
Read More
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category of […]
Read More
As millions lose weight on GLP-1s, they’re starting to turn to retailers to refresh their wardrobes
Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a suburb of St. Louis, Missouri gave away her favorite sundresses and other form-fitting outfits, thinking she’d never be those smaller sizes again. Now, after losing about 28 pounds while taking GLP-1 drug Wegovy, she said she has […]
Read More
Iran says U.S. breached ceasefire, Anthropic’s court loss, rate cut odds and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. We’re minutes away from the release of February’s personal consumption expenditures price index. Watch CNBC live for the numbers and analysis. Stock futures are lower this morning. All three major averages posted major gains yesterday. Here are five key things […]
Read More
Inside India newsletter: Tariffs and Iran war threaten India’s $100 billion garments export goal
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India“ — your one-stop destination for stories and developments from the world’s fastest growing large economy. Just as India’s textile industry was beginning to stabilize after U.S. tariffs, it received another blow. Industry leaders tell me the Iran […]
Read More
Trump’s Iran deadline, the Altman-Musk feud, Novo’s Wegovy pill and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning, and congratulations to everyone who had the Michigan Wolverines winning their March Madness bracket. Stock futures are lower this morning after all three major averages closed Monday’s session higher. Here are five key things investors need to know to start […]
Read More